Sanofi
SNY
$48.66
$0.310.64%
NASDAQ
| 12/31/2025 | 06/30/2025 | 12/31/2024 | 09/30/2024 | ||
|---|---|---|---|---|---|
| Revenue | 13.16B | 11.34B | 10.24B | 13.37B | |
| Total Other Revenue | 1.05B | 840.98M | 833.99M | 901.49M | |
| Total Revenue | 14.21B | 12.18B | 11.08B | 14.27B | |
| Cost of Revenue | 4.23B | 3.40B | 3.48B | 4.03B | |
| Gross Profit | 9.98B | 8.79B | 7.60B | 10.24B | |
| SG&A Expenses | 3.28B | 2.63B | 2.67B | 2.45B | |
| Depreciation & Amortization | 626.28M | 429.00M | 436.29M | 440.85M | |
| Other Operating Expenses | 1.38B | 1.37B | 691.01M | 1.12B | |
| Total Operating Expenses | 12.18B | 9.99B | 9.51B | 10.03B | |
| Operating Income | 2.03B | 2.19B | 1.56B | 4.24B | |
| Income Before Tax | -1.34B | 1.66B | 686.71M | 3.83B | |
| Income Tax Expenses | -405.11M | 261.03M | 114.79M | 751.97M | |
| Earnings from Continuing Operations | -939.43M | 1.40B | 571.92M | 3.08B | |
| Earnings from Discontinued Operations | 15.13M | 3.07B | -197.83M | 43.98M | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -8.15M | -4.54M | -11.25M | -31.88M | |
| Net Income | -932.44M | 4.47B | 362.84M | 3.09B | |
| EBIT | 2.03B | 2.19B | 1.56B | 4.24B | |
| EBITDA | 4.06B | 3.05B | 3.11B | 5.05B | |
| EPS Basic | -0.77 | 3.67 | 0.29 | 2.47 | |
| Normalized Basic EPS | 1.02 | 1.14 | -- | -- | |
| EPS Diluted | -0.77 | 3.67 | 0.28 | 2.47 | |
| Normalized Diluted EPS | 1.02 | 1.14 | -- | -- | |
| Average Basic Shares Outstanding | 1.21B | 1.22B | 1.25B | 1.25B | |
| Average Diluted Shares Outstanding | 1.21B | 1.22B | 1.26B | 1.25B | |
| Dividend Per Share | 4.80 | -- | 4.18 | -- | |
| Payout Ratio | -595.76% | -- | 84.60% | -- | |